IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer
نویسندگان
چکیده
Abstract Breast cancer bone metastasis is currently incurable, ~75% of patients with late-stage breast develop disease recurrence in and available treatments are only palliative. We have previously shown that production the pro-inflammatory cytokine interleukin-1B (IL-1B) by cells drives preclinical vivo models. In current study, we investigated how IL-1B from tumour microenvironment interact to affect primary growth through regulation immune system, whether targeting IL-1 driven changes response improves standard care therapy for metastasis. Using syngeneic IL-1B/IL1R1 knock out mouse models combination genetic manipulation overexpress IL-1B/IL1R1, found signalling elicited an opposite tumours compared metastases. tumours, inhibited growth, impairing infiltration innate cell subsets potential anti-cancer functions but promoted enhanced migration. bone, stimulated development osteolytic cancer, combining (Doxorubicin Zoledronic acid) receptor antagonist Anakinra both had effects on treatment, its anti-inflammatory signature was maintained therapy. These data suggest may provide a useful therapeutic approach inhibit improve efficacy patients.
منابع مشابه
Evaluation of Strontium-89 in palliative treatment of widespread and painful bone metastases due to breast and prostate cancer [Persian]
Treatment of bone metastases comprises over 10% of the workload of a radiation-oncology center. Bone metastases produce severe pain and immobility, necessitate narcotic use, and reduce the quality of life. A good palliative treatment must be complete, free from side effects and fast; Thus we decided to evaluate Strontium-89 (89Sr) effectivity for palliation of breast and prostate cancer b...
متن کاملthe study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region
چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...
15 صفحه اولIL-1 drives breast cancer growth and bone metastasis in vivo
BACKGROUND We have recently identified interleukin 1B (IL-1B) as a potential biomarker for predicting breast cancer patients at increased risk for developing bone metastasis. In mouse models, IL-1B and its receptor (IL-1R1) are upregulated in breast cancer cells that metastasise to bone compared with cells that do not. We have now investigated the functional role of IL-1 by blocking IL-1R signa...
متن کاملSurgical treatment of pulmonary metastases from primary tumours of bone.
Interest in lung resection for metastatic malignant disease has steadily increased since it became apparent that in carefully selected patients the results in terms of prolongation of life could be surprisingly good. Indeed the outcome after such resection for metastases of all kinds compares favourably with those to be expected following resection of primary tumours of the lung (Smith 1963, Cl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: NPJ breast cancer
سال: 2021
ISSN: ['2374-4677']
DOI: https://doi.org/10.1038/s41523-021-00305-w